Authors:
Silvers, LE
Ellenberg, SS
Wise, RP
Varricchio, FE
Mootrey, GT
Salive, ME
Citation: Le. Silvers et al., The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990-1997, PHARMA D S, 10(4), 2001, pp. 279-285
Authors:
De Gruttola, VG
Clax, P
DeMets, DL
Downing, GJ
Ellenberg, SS
Friedman, L
Gail, MH
Prentice, R
Wittes, J
Zeger, SL
Citation: Vg. De Gruttola et al., Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop, CONTR CL TR, 22(5), 2001, pp. 485-502
Citation: Rm. Califf et Ss. Ellenberg, Statistical approaches and policies for the operations of Data and Safety Monitoring Committees, AM HEART J, 141(2), 2001, pp. 301-305
Authors:
Braun, MM
Mootrey, GT
Salive, ME
Chen, RT
Ellenberg, SS
Citation: Mm. Braun et al., Infant immunization with acellular pertussis vaccines in the United States: Assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS), PEDIATRICS, 106(4), 2000, pp. NIL_43-NIL_49
Citation: R. Temple et Ss. Ellenberg, Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 1: Ethical and scientific issues, ANN INT MED, 133(6), 2000, pp. 455-463
Citation: Ss. Ellenberg et R. Temple, Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 2: Practical issues and specific cases, ANN INT MED, 133(6), 2000, pp. 464-470